Researchers from Shenzhen University and affiliated organizations detailed the preclinical characterization of a synergistic intravesical instillation of fenbendazole (FBZ) and CRISPR-Cas13a-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback